Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Depression

Ketamine steps out of the darkness

Nature volume 533, pages 477–478 (2016)Cite this article

Subjects

The way in which ketamine exerts its antidepressant effects has been perplexing. Evidence that a metabolite of the drug is responsible, and acts on a different target from ketamine, might be the key to an answer. See Article p.481

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Metabolite mediator of ketamine.

Notes

  1. See all news & views

References

  1. Styron, W. Darkness Visible: A Memoir of Madness (Random house, 1990).

    Google Scholar 

  2. Trevino, K., McClintock, S. M., McDonald Fischer, N., Vora, A. & Husain, M. M. Ann. Clin. Psychiatry 26, 222–232 (2014).

    PubMed  Google Scholar 

  3. Berman, R. M. et al. Biol. Psychiatry 47, 351–354 (2000).

    Article  CAS  Google Scholar 

  4. Zarate, C. A. Jr et al. Arch. Gen. Psychiatry 63, 856–864 (2006).

    Article  CAS  Google Scholar 

  5. McGirr, A. et al. Psychol. Med. 45, 693–704 (2015).

    Article  CAS  Google Scholar 

  6. DiazGranados, N. et al. J. Clin. Psychiatry 71, 1605–1611 (2010).

    Article  CAS  Google Scholar 

  7. Zanos, P. et al. Nature 533, 481–486 (2016).

    Article  ADS  CAS  Google Scholar 

  8. Anis, N. A., Berry, S. C., Burton, N. R. & Lodge, D. Br. J. Pharmacol. 79, 565–575 (1983).

    Article  CAS  Google Scholar 

  9. Collingridge, G. L., Kehl, S. J. & McLennan, H. J. Physiol. (Lond.) 334, 33–46 (1983).

    Article  CAS  Google Scholar 

  10. Bliss, T. V. P. & Lømo, T. J. Physiol. (Lond.) 232, 331–356 (1973).

    Article  CAS  Google Scholar 

  11. Morris, R. G., Anderson, E., Lynch, G. S. & Baudry, M. Nature 319, 774–776 (1986).

    Article  ADS  CAS  Google Scholar 

  12. Nabavi, S. et al. Nature 511, 348–352 (2014).

    Article  ADS  CAS  Google Scholar 

  13. Ebert, B., Mikkelsen, S., Thorkildsen, C. & Borgbjerg, F. M. Eur. J. Pharmacol. 333, 99–104 (1997).

    Article  CAS  Google Scholar 

  14. Autry, A. E. et al. Nature 475, 91–95 (2011).

    Article  CAS  Google Scholar 

  15. Carrier, N. & Kabbaj, M. Neuropharmacology 70, 27–34 (2013).

    Article  CAS  Google Scholar 

  16. Li, N. et al. Science 329, 959–964 (2010).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Roberto Malinow is in the Department of Neurosciences, Division of Biology, School of Medicine, and in the Section of Neurobiology, University of California, San Diego, La Jolla, California 92093, USA.,

    Roberto Malinow

Authors
  1. Roberto Malinow
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto Malinow.

Related links

Related links

Related links in Nature Research

Depression: The best way forward

Neuroscience: Along memory lane

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Malinow, R. Ketamine steps out of the darkness. Nature 533, 477–478 (2016). https://doi.org/10.1038/nature17897

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature17897

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing